Neogen Corporation (NEOG)
NEOGNASDAQ-GSBiotechnology: In Vitro & In Vivo Diagnostic Substances
$11.67
-0.4100 (-3.39%) today
At the close, Nov 10, 4:00 PM ET. After hours $11.38 -2.45%
- Market cap
- $2.55bn
- P/E
- 37.6
- EPS, last 4 quarters
- $0.3100
- Dividend yield
- –
- Day range
- $11.64 to $11.91
- 52-week range
- $5.37 to $14.26
- Average volume
- 3.92m
- Previous close
- $12.08
Analysts
3 coveringBuy2 buy, 1 hold, 0 sell
Targets a year out average $14.00, +20.0% from here
Earnings
next estimate $0.0500Next report
Nov 2025
+60.0%
Feb 2026
+300.0%
May 2026
+166.7%
Aug 2026
+75.0%
estimate reported, and the surprise
Financials
| Quarter | Nov 2025 | Feb 2026 | May 2026 | Aug 2026 |
|---|---|---|---|---|
| Revenue | $224.68m | $211.22m | $225.30m | $222.80m |
| Gross profit | $106.65m | $99.05m | $107.80m | $105.50m |
| Operating income | -$5.37m | -$3.23m | $3.10m | -$1.80m |
| Net income | -$15.89m | -$17.01m | -$11.30m | -$11.90m |
Last four quarters: revenue $884.00m, margin -6.3%, free cash flow $49.80m
News
8 latest- Neogen (NEOG) Up 6.7% Since Last Earnings Report: Can It Continue?Zacks · 5 days ago
- Neogen Corporation Expects Genomics Sale Regulatory Review to Conclude in early 2027Fintel · 6 days ago
- Neogen Corporation Shareholders Approve Amended and Restated Omnibus Incentive PlanFintel · Oct 26, 2026
- NEOG vs. WFCF: Which Food Safety Stock Has Better Prospects?Zacks · Oct 20, 2026
- Tuesday 10/13 Insider Buying Report: IMSR, NEOG BNK Invest · Oct 13, 2026
- Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve CannabisZacks · Oct 12, 2026
- 3 Medical Product Stocks Positioned to Ride on the Industry TailwindsZacks · Oct 9, 2026
- Neogen Investor Day Sets Path for Growth, 30% EBITDA Margin by 2031MarketBeat · Oct 7, 2026
The company
Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- neogen.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.